Update on ischemic heart disease and critical care cardiology.
Jiménez-Candil J, Díaz-Castro O, Barrabés JA, et al.
Rev Esp Cardiol 2013 Mar;66(3):198-204.

Innovations in heart rhythm disturbances: cardiac electrophysiology, arrhythmias, and cardiac pacing.
Moya A, Sancho-Tello MJ, Arenal A, et al.
Rev Esp Cardiol 2013 Feb;66(2):116-123.

Update in Cardiology: vascular risk and cardiac rehabilitation.
Galve E, Castro A, Cordero A, et al; en representación de la Sección de Riesgo Vascular y Rehabilitación Cardiaca de la Sociedad Española de Cardiología.
Rev Esp Cardiol 2013 Feb;66(2):124-130.

Summary of the clinical studies reported in the annual scientific sessions of the american heart association (Los Angeles, CA, USA, november 3-7, 2012).
Avanzas P, Bayes-Genis A, Isla LP, Sanchis J, Heras M.
Rev Esp Cardiol 2013 Jan;66(1):55.e1-55.e11.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O’Gara PT, Kushner FG, Ascheim DD, et al.
J Am Coll Cardiol 2013 Jan 29;61(4):e78-140.

Grupo de Trabajo para el manejo del infarto agudo de miocardio con elevación del segmento ST de la Sociedad Europea de Cardiología (ESC).
Steg G, James SK, Atar D, et al.
Rev Esp Cardiol 2013 Jan;66(1):53.e1-53.e46.

The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.
Feldman D, Pamboukian SV, Teuteberg JJ, et al.
J Heart Lung Transplant 2013 Feb;32(2):157-187.

Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug.
López-Mínguez JR, Eldoayen-Gragera J, González-Fernández R, et al.
Rev Esp Cardiol 2013 Feb;66(2):90-97.

Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds:="" the="" evaluation="" of="" resynchronization="" therapy="" for="" heart="" failure="" lesser-earth="" trial="" strong="">
Thibault B, Harel F, Ducharme A, et al; LESSER-EARTH Investigators.
Circulation 2013 Feb 26;127(8):873-881.

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: Analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR, Hellkamp AS, Lokhnygina Y, et al.
J Am Coll Cardiol 2013 Feb 12;61(6):651-658.

Scar extent, left ventricular end-diastolic volume, and wall motion abnormalities identify high-risk patients with previous myocardial infarction: a multiparametric approach for prognostic stratification.
Di Bella G, Siciliano V, Aquaro GD, et al.
Eur Heart J 2013 Jan;34(2):104-111.

Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score.
Senni M, Parrella P, De Maria R, et al.
Int J Cardiol. 2013 Feb 20;163(2):206-211.

Este artículo no contiene material bibliografico

Para descargar el PDF del artículo
Selección de artículos relevantes, guías y consensos publicados en enero y febrero 2013

Haga click aquí